ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Options for Indian Pharmaceutical Industry in the Changing Environment

With the shift to a strong patent law, Indian pharmaceutical companies are rapidly shifting their focus to the generics market of the developed world. But even as India has become a net exporter of pharmaceuticals, import dependence on active pharmaceutical ingredients has steadily increased over the last 10 years. As far as the Indian affiliates of the multinational pharmaceutical companies are concerned, their shares of both the active pharmaceutical ingredients and formulations are declining and their "investment" preferences have shifted towards financial securities. A process of consolidation through mergers and acquisitions has been underway, which apart from increasing market concentration, has been a key element of firm strategy to tap business opportunities along the value chain in the domestic as well as the overseas markets. In the field of R&D, with no Indian pharmaceutical company being equipped to take a potential drug from the investigational stage to the stage of final market launch, collaboration with multinational corporations is the norm, resulting in biases in the choice of therapeutic areas towards lifestyle-related diseases.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top